ESMO 2025 (poster): Gut microbiome composition associates with clinical response to immune checkpoint inhibitor (ICI) therapy across multiple patient cohorts17 October 2025View Poster: ESMO 2025 (poster): Gut microbiome composition associates with clinical response to immune checkpoint inhibitor (ICI) therapy across multiple patient cohorts https://microbiotica.com/wp-content/uploads/2024/06/Microbiotica_Logo_RGB.svg 0 0 immunocity https://microbiotica.com/wp-content/uploads/2024/06/Microbiotica_Logo_RGB.svg immunocity2025-10-17 09:47:032026-02-20 09:51:53ESMO 2025 (poster): Gut microbiome composition associates with clinical response to immune checkpoint inhibitor (ICI) therapy across multiple patient cohorts
